213 related articles for article (PubMed ID: 26046940)
1. Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2.
Bueren-Calabuig JA; Michel J
PLoS Comput Biol; 2015 Jun; 11(6):e1004282. PubMed ID: 26046940
[TBL] [Abstract][Full Text] [Related]
2. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
[TBL] [Abstract][Full Text] [Related]
3. Impact of Ser17 Phosphorylation on the Conformational Dynamics of the Oncoprotein MDM2.
Bueren-Calabuig JA; Michel J
Biochemistry; 2016 May; 55(17):2500-9. PubMed ID: 27050388
[TBL] [Abstract][Full Text] [Related]
4. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
Verkhivker GM
PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
[TBL] [Abstract][Full Text] [Related]
5. Markov models of the apo-MDM2 lid region reveal diffuse yet two-state binding dynamics and receptor poses for computational docking.
Mukherjee S; Pantelopulos GA; Voelz VA
Sci Rep; 2016 Aug; 6():31631. PubMed ID: 27538695
[TBL] [Abstract][Full Text] [Related]
6. Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulation.
Dastidar SG; Raghunathan D; Nicholson J; Hupp TR; Lane DP; Verma CS
Cell Cycle; 2011 Jan; 10(1):82-9. PubMed ID: 21191186
[TBL] [Abstract][Full Text] [Related]
7. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
Pantelopulos GA; Mukherjee S; Voelz VA
Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
[TBL] [Abstract][Full Text] [Related]
8. Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.
Åberg E; Karlsson OA; Andersson E; Jemth P
J Phys Chem B; 2018 Jul; 122(27):6899-6905. PubMed ID: 29878773
[TBL] [Abstract][Full Text] [Related]
9. Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction.
Gureev M; Novikova D; Grigoreva T; Vorona S; Garabadzhiu A; Tribulovich V
J Comput Aided Mol Des; 2020 Jan; 34(1):55-70. PubMed ID: 31781989
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.
Dastidar SG; Lane DP; Verma CS
BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S6. PubMed ID: 19958516
[TBL] [Abstract][Full Text] [Related]
11. Binding induced folding in p53-MDM2 complex.
Chen HF; Luo R
J Am Chem Soc; 2007 Mar; 129(10):2930-7. PubMed ID: 17302414
[TBL] [Abstract][Full Text] [Related]
12. MDM4 binds ligands via a mechanism in which disordered regions become structured.
Sanchez MC; Renshaw JG; Davies G; Barlow PN; Vogtherr M
FEBS Lett; 2010 Jul; 584(14):3035-41. PubMed ID: 20515689
[TBL] [Abstract][Full Text] [Related]
13. How Does the Recently Discovered Peptide MIP Exhibit Much Higher Binding Affinity than an Anticancer Protein p53 for an Oncoprotein MDM2?
Yamada T; Hayashi T; Hikiri S; Kobayashi N; Yanagawa H; Ikeguchi M; Katahira M; Nagata T; Kinoshita M
J Chem Inf Model; 2019 Aug; 59(8):3533-3544. PubMed ID: 31282659
[TBL] [Abstract][Full Text] [Related]
14. Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation.
McCoy MA; Gesell JJ; Senior MM; Wyss DF
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1645-8. PubMed ID: 12552135
[TBL] [Abstract][Full Text] [Related]
15. The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2.
Worrall EG; Worrall L; Blackburn E; Walkinshaw M; Hupp TR
J Mol Biol; 2010 May; 398(3):414-28. PubMed ID: 20303977
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
Hu G; Xu S; Wang J
Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
Niu RJ; Zheng QC; Zhang JL; Zhang HX
J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
[TBL] [Abstract][Full Text] [Related]
18. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
[TBL] [Abstract][Full Text] [Related]
19. Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.
Zhan C; Varney K; Yuan W; Zhao L; Lu W
J Am Chem Soc; 2012 Apr; 134(15):6855-64. PubMed ID: 22444248
[TBL] [Abstract][Full Text] [Related]
20. Binding Ensembles of
Lang L; Perez A
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
